2011 Issues   /   Research

Recent Psychiatric Studies

USM By U.S. Medicine
March 10, 2011

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

Purpose: Stress-related disorders are among the most prevalent and expensive medical consequences of participation in military operations. Omega-3 fatty acids EPA/DHA derived from fish oil are known to benefit both neuronal development in the young, and cognition and mood in various populations.

It is possible that soldiers receiving Omega-3 EPA/DHA will exhibit significantly higher cognitive performance, better affect/mood state, and less combat stress symptomatology compared to the placebo after 12 weeks of supplementation. A goal would be to reduce the prevalence of combat stress injuries in military personnel.

This study is enrolling participants by invitation only.

Sponsor: DoD

Collaborator: GlaxoSmithKline

ClinicalTrials.gov Identifier: NCT01216982

Behavioral Activation for Post Traumatic Stress Disorder (PTSD)/ Depression Treatment in Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans

Purpose: The present study is a randomized, controlled trial that compares behavioral activation to usual VA care as early psychotherapeutic interventions for OIF/OEF veterans with post traumatic stress disorder, or PTSD and major depressive disorder (PTSD/MDD).

Sponsor: VA

ClinicalTrials.gov Identifier: NCT00805532

Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder

Purpose: The objective of the proposed study is to conduct a systematic comparison of post traumatic stress disorder outcomes for veterans receiving exposure therapy via telemedicine versus in-person care. The primary aim is to determine feasibility: whether telemedicine can be used as a tool to extend effective, specialized mental health services, such as Prolonged Exposure therapy (PE; a therapy designed to help clients face fears related to a traumatic event), to veterans with limited access to care. A secondary aim is to determine if therapy delivered by telemedicine affects the quality of care in terms of clinical outcomes and the quality of patient-therapist interaction. A tertiary aim is to examine whether results from neuropsychological testing predict treatment outcomes.

Sponsor: Veterans Medical Research Foundation

Collaborators: DoD, University of Pennsylvania

ClinicalTrials.gov Identifier: NCT01158001

Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes

Purpose: This study uses functional magnetic resonance imaging to learn how the brain functions in adolescents receiving fluoxetine (Prozac®) cognitive behavioral therapy or interpersonal therapy for anxiety or depression in children/adolescents.

Sponsor: NIMH

ClinicalTrials.gov Identifier: NCT00018057

back to March articles


Related Articles

First-Ever Study Focuses on How Well VHA Cares for TIA Patients

INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help avoid acute events altogether.

Link Between Pain, Brain Disruption in Gulf War Veterans

MADISON, WI — Chronic musculoskeletal pain (CMP) affects about one-fourth of the 700,000 veterans deployed during the Persian Gulf War in 1990-1991. A study in the journal Pain pointed out that the cause of their... View Article


U.S. Medicine Recommends


More From research

Research

First-Ever Study Focuses on How Well VHA Cares for TIA Patients

INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help avoid acute events altogether.

Research

Link Between Pain, Brain Disruption in Gulf War Veterans

VA’s Consolidated Mail Outpatient Pharmacy (CMOP) in Charleston, SC. New legislation is seeking to increase clinician input into formulary decisionmaking. WASHINGTON — Legislation to prevent VA from outsourcing creation of its drug formulary and to... View Article

Research

VA Patients Lack Testing to Optimize CLL Treatment

SALT LAKE CITY — The presence of deletion 17p (del17), determined by chromosome analysis and/or fluorescence in situ hybridization (FISH), is a strong negative prognostic marker in chronic lymphocytic leukemia (CLL), according to a report in the Journal of Clinical Oncology.1

Research

Early Relapse After AHCT Bad Sign in Multiple Myeloma

VA’s Consolidated Mail Outpatient Pharmacy (CMOP) in Charleston, SC. New legislation is seeking to increase clinician input into formulary decisionmaking. WASHINGTON — Legislation to prevent VA from outsourcing creation of its drug formulary and to... View Article

Research

Laparoscopic, Robotic Surgeries Equivalent for Pancreatic Cancer

Pancreatic cancer patients increasingly are receiving minimally invasive pancreaticoduodenectomy (MIPD).

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up